These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 3019570

  • 1. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
    Torsteinsdottir S, Masucci MG, Brautbar C, Lenoir G, Klein G, Klein E.
    Cell Immunol; 1986 Apr 01; 98(2):453-66. PubMed ID: 3019570
    [Abstract] [Full Text] [Related]

  • 2. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
    Torsteinsdottir S, Masucci MG, Szigeti R, Bishara A, Brautbar C, Klein G, Klein E.
    Mol Biol Med; 1984 Aug 01; 2(4):285-99. PubMed ID: 6443579
    [Abstract] [Full Text] [Related]

  • 3. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.
    Torsteinsdottir S, Masucci MG, Ehlin-Henriksson B, Brautbar C, Ben Bassat H, Klein G, Klein E.
    Proc Natl Acad Sci U S A; 1986 Aug 01; 83(15):5620-4. PubMed ID: 3016710
    [Abstract] [Full Text] [Related]

  • 4. Stimulation with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines generates HLA class I-specific CTLs with different target cell avidity.
    Torsteinsdottir S, Cuomo L, Klein E, Masucci MG.
    Cell Immunol; 1991 Oct 15; 137(2):501-13. PubMed ID: 1654213
    [Abstract] [Full Text] [Related]

  • 5. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
    Hank JA, Sondel PM.
    Hum Immunol; 1984 Apr 15; 9(4):211-9. PubMed ID: 6201468
    [Abstract] [Full Text] [Related]

  • 6. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE, Spits H.
    J Immunol; 1984 Jan 15; 132(1):510-9. PubMed ID: 6197458
    [Abstract] [Full Text] [Related]

  • 7. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR.
    Eur J Immunol; 1995 May 15; 25(5):1374-84. PubMed ID: 7774641
    [Abstract] [Full Text] [Related]

  • 8. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D, Radka SF, Igarashi M, Kreider BL, Ferrone S.
    J Immunol; 1986 Jul 15; 137(2):400-7. PubMed ID: 2941479
    [Abstract] [Full Text] [Related]

  • 9. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Jul 15; 133(1):422-7. PubMed ID: 6609990
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
    Masucci MG, Torsteindottir S, Colombani J, Brautbar C, Klein E, Klein G.
    Proc Natl Acad Sci U S A; 1987 Jul 15; 84(13):4567-71. PubMed ID: 3037521
    [Abstract] [Full Text] [Related]

  • 11. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB.
    Int Immunol; 1992 Nov 15; 4(11):1283-92. PubMed ID: 1282031
    [Abstract] [Full Text] [Related]

  • 12. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules.
    Chen BP, DeMars R, Hank JA, Sondel PM.
    Cell Immunol; 1988 Sep 15; 115(2):363-72. PubMed ID: 2842068
    [Abstract] [Full Text] [Related]

  • 13. Evidence for the involvement of HLA-DR antigens in restricted cytotoxicity by fetal calf serum-specific human T cells.
    Misko IS, Pope JH, Kane RG, Bashir H, Doran T.
    Hum Immunol; 1982 Nov 15; 5(3):183-97. PubMed ID: 6184349
    [Abstract] [Full Text] [Related]

  • 14. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G, Rickinson AB.
    Eur J Immunol; 1987 Jul 15; 17(7):1007-13. PubMed ID: 2440688
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
    Tanaka Y, Sugamura K, Hinuma Y.
    J Immunol; 1982 Mar 15; 128(3):1241-5. PubMed ID: 6173428
    [Abstract] [Full Text] [Related]

  • 16. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component.
    Misko IS, Sculley TB, Schmidt C, Moss DJ, Soszynski T, Burman K.
    Cell Immunol; 1991 Feb 15; 132(2):295-307. PubMed ID: 1846323
    [Abstract] [Full Text] [Related]

  • 17. Use of Epstein-Barr virus-transformed, autologous B-lymphoblastoid cells as antigen-presenting cells for establishment and maintenance of dengue virus-specific, human cytotoxic T lymphocyte clones.
    Livingston PG, Kurane I, Ennis FA.
    J Virol Methods; 1997 Aug 15; 67(1):77-84. PubMed ID: 9274820
    [Abstract] [Full Text] [Related]

  • 18. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
    van de Griend RJ, Giphart MJ, Van Krimpen BA, Bolhuis RL.
    J Immunol; 1984 Sep 15; 133(3):1222-9. PubMed ID: 6205072
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.